
Opinion|Videos|August 2, 2024
High-Risk Populations for Severe Pneumococcal Infection
Key opinion leaders identify high-risk populations for invasive pneumococcal disease, explain the underlying factors contributing to their increased susceptibility, and offer strategies to improve suboptimal vaccination rates, particularly among historically underserved communities.
Advertisement
Episodes in this series

- Who are the high-risk
populations for developing invasive pneumococcal disease?
- What is the rationale for why certain populations are at risk for severe pneumococcal infections?
- How can we improve inadequate pneumococcal vaccine uptake rates, specifically in historically marginalized groups?
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
mRNA-1283 Associated With Lower Risk of Medically Attended COVID-19 Than BNT162b2 in Older Veterans
2
Survodutide for Obesity and CV Risk: Liver, Lipids, and Beyond
3
Long-Acting HIV Injectables in Viremia and New Tenofovir-Free Oral Options
4
What Pharmacists Should Know About Transitioning Patients to Buprenorphine
5

